Berlin, Germany, September 2nd-6th, 2012

Prof. Dario Neri will give a plenary presentation at the symposium ‘Antibody-Drug Conjugates – Finally Ready  for Prime Time’ to be held as part of the EFMC-ISMC XXIInd International Symposium on Medicinal Chemistry. The title of the presentation will be ‘Targeting tumors with antibody-drug conjugates and other armed antibodies: from the bench to the clinic’ .

Rimini, Italy, 30th May – 1st  June, 2012

Dr Leonardo Giovannoni, Head of Clinical Operations, will present at the 52nd Symposium of AFI (Associazione Farmaceutici Industria) in Rimini (Italy), 30th May – 1st  June 2012. The title of his presentation will be:  “Philogen’s pipeline in oncology and rheumatoid arthritis: rationale and clinical results”.

Prague, April 17th – 20th, 2012

Dr Leonardo Giovannoni, Dr Leonardo Giovannoni, Head of Clinical Operations, will present at the 8th Annual Bioprocess International Conference in Prague, 17th – 20th April 2012. The title of his presentation will be:  “Process Development of armed antibody for the therapy of cancer and rheumatoid arthritis”.

Chicago, USA, April 1st -4th, 2012

Prof. Dario Neri will present a plenary lecture at AACR, April 1st -4th Chicago.

London, UK, February 15th – 16th, 2012

Dr Leonardo Giovannoni, Head of Clinical Operations, will present at the 5th  Bioinnovation Leaders Summit in London, 15th – 16th February 2012. The title of his presentation will be: “Designing a downstream protein  purification process using recent new developments”.

Washington, USA, February 1st-2nd, 2012

Dr. Hans Menssen will present at the ‘World RadioImmunoConjugate Summit – Recognizing the Potential of Radioimmunoconjugates for Cancer Treatment and Imaging’ in Washington, 1st-2nd February, 2012. The title of the presentation will be ‘Clinical Trial Case Study: RIT in Combination with External Beam Radiation’.